The 1 AI Chip Stock I'd Buy Hand Over Fist in This Sell-Off -- and It Isn't Nvidia.

The market is mislabeling this as a pricing-power shock when the bigger mechanism is a bottleneck shift: custom silicon can pressure design-layer margins without impairing the foundry that sits behind every winning architecture. That makes TSM the cleaner expression of AI capex because it monetizes demand regardless of whose chip ultimately wins, and it also captures the second-order rise in advanced packaging and node migration that the hyperscalers cannot in-source quickly. The real supply-chain beneficiaries extend into equipment vendors, but TSM has the best mix of demand visibility and capacity leverage.

Near term, the stock can still be choppy because investors will focus on capex intensity and the drag from Arizona spend before they credit the revenue runway. That creates a 1-3 month window where the numbers look great but the free-cash-flow debate dominates; if margins stop expanding for even two quarters, the multiple can compress despite strong top-line growth. Over 6-18 months, the key falsifier is not customer chip redesigns but a meaningful slowdown in leading-edge utilization or a guidance reset below the current growth regime.

NVDA is the most exposed to multiple compression because the market is pricing scarcity into the design layer, and that scarcity narrative is exactly what custom silicon challenges. AVGO is a legitimate beneficiary of custom chips, but the market already recognizes that, so the upside looks more capped than TSM's. MU remains a cyclical trade, not a structural AI compounder; unless HBM pricing stays tight into the next memory upcycle, the recent drawdown may be only a reset, not a bottom.